Protagonist Therapeutics: 3Q Earnings Snapshot
NEWARK, Calif. (AP) _ Protagonist Therapeutics Inc. (PTGX) on Tuesday reported a loss of $8.7 million in its third quarter.
The Newark, California-based company said it had a loss of 38 cents per share.
The biopharmaceutical company posted revenue of $6.1 million in the period.
Protagonist Therapeutics shares have dropped 58 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $8.69, a drop of 41 percent in the last 12 months.